Exosomes emerged as valuable sources of disease biomarkers and new therapeutic tools.
However, extracellular vesicles isolation with exosome-like characteristics from certain …

Abstract Recently, extracellular vesicles (EVs)—including exosomes, microvesicles, and
others—have attracted interest as cell-derived biotherapeutics and drug delivery vehicles for …

Extracellular vesicles represent a rich source of novel biomarkers in the diagnosis and
prognosis of disease. However, there is currently limited information elucidating the most …

Extracellular vesicles (EVs), such as exosomes and microvesicles, are released by different
cell types and participate in physiological and pathophysiological processes. EVs mediate …

The potential of exosomes as biomarker resources for diagnostics, prognostics and even for
therapeutics is an area of intense research. Despite the various approaches available, there …

Secreted membrane‐enclosed vesicles, collectively called extracellular vesicles (EVs),
which include exosomes, ectosomes, microvesicles, microparticles, apoptotic bodies and …

In the past decade, extracellular vesicles (EVs) have been recognized as potent vehicles of
intercellular communication, both in prokaryotes and eukaryotes. This is due to their capacity …

Despite an enormous interest in the role of extracellular vesicles, including exosomes, in
cancer and their use as biomarkers for diagnosis, prognosis, drug response and recurrence …

Growing interest in extracellular vesicles (EVs, including exosomes and microvesicles) as
therapeutic entities, particularly in stem cell-related approaches, has underlined the need for …

Plasma and other body fluids contain cell-derived extracellular vesicles (EVs), which
participate in physiopathological processes and have potential biomedical applications. In …